Latham & Watkins, Kirkland & Ellis and Weil, Gotshal & Manges are advising on the acquisition of French natural healthcare group, Havea by London-based private equity group, BC partners.
Paris headquartered Havea was founded in 1975 and achieved sales of €212 million in 2021, according to a statement by current majority investor 3i.
BC partners has over €20 billion of assets under management in private equity, private credit and real estate, the statement added.
The deal has been reported to be worth over $1 billion. Latham is advising BC partners on the corporate side of the acquisition, according to a press release by the firm. The Paris-based team was led by corporate partner Denis Criton and advice on tax matters was provided by partner Olivia Rauch-Ravisé, on anti-trust matters by partner Adrien Giraud and on regulatory and life sciences matters by partner Eveline Van Keymeule. A Kirkland team is advising on the financing of the acquisition. A statement from the firm said the Kirkland team consisted of debt finance partners Kanesh Balasubramaniam, Kalish Mullen and Neel Sachdev. The 3i group selling Havea alongside its co-investors Cathay Capital are being advised by a Paris-based Weil team led by corporate partner Jean Beauchataud, according to a person with knowledge of the matter.
According to a statement by 3i, the deal is set to complete in the fourth quarter of 2022.
The healthcare sector has continued to provide law firms with work. In May, an array of firms including Cleary Gottlieb Steen & Hamilton advised on the spin-off of GSK and Pfizer joint venture Haleon.